DCTH Delcath Systems, Inc. - Common Stock
$17.21
株価 · 8月 19, 2026
ファンダメンタルズ（時点） 8月 6, 2026
52週レンジ
$8–$17
98% of range
アナリスト評価
BUY
12 analysts
目標株価
$24
+39% upside
P/E (TTM)
245.9
ROE
2.5%
純利益率
3.2%
Delcath Systems, Inc. - Common Stock について Wikipediaからの企業概要
Delcath Systems, Inc. is a publicly traded specialty pharmaceutical and medical device company, that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based in Queensbury, New York, the company has an intellectual property portfolio consisting of 28 patents worldwide. Delcath's Percutaneous Hepatic Perfusion (PHP) is currently undergoing Phase II and Phase III trials against tumors in the liver. Delcath has a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute and has received Fast Track and a Special Protocol Assessment from the Food and Drug Administration for its use of melphalan in treating unresectable liver tumors. PHP, also known as the Delcath System, is tested for the treatment of metastatic melanoma in the liver and for primary liver cancer and metastatic hepatic malignancies from neuroendocrine cancers and adenocarcinomas, as well as patients with melanoma who previously received isolated perfusion. Chemotherapy is usually delivered intravenously, although a number of agents can be administered orally.
続きを読む
Delcath Systems, Inc. (NASDAQ: DCTH) is a publicly traded specialty pharmaceutical and medical device company, that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based in Queensbury, New York, the company has an intellectual property portfolio consisting of 28 patents worldwide. Delcath's Percutaneous Hepatic Perfusion (PHP) is currently undergoing Phase II and Phase III trials against tumors in the liver. Delcath has a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute and has received Fast Track and a Special Protocol Assessment from the Food and Drug Administration for its use of melphalan in treating unresectable liver tumors. PHP, also known as the Delcath System, is tested for the treatment of metastatic melanoma in the liver and for primary liver cancer and metastatic hepatic malignancies from neuroendocrine cancers and adenocarcinomas, as well as patients with melanoma who previously received isolated perfusion. Chemotherapy is usually delivered intravenously, although a number of agents can be administered orally (e.g. specialty drugs, melphalan (trade name Alkeran), busulfan, capecitabine).
## Phase III melanoma trial enrolling
University of Pittsburgh Medical Center
National Cancer Institute in Bethesda, Maryland
Albany Medical Center in Albany, New York
John Wayne Cancer Center in Santa Monica, California
Moffitt Cancer Center in Tampa, Florida
Morristown Memorial Hospital in Morristown, New Jersey
Providence Cancer Center in Portland, Oregon
St. Luke's Cancer Center of Bethlehem, Pennsylvania
Swedish Medical Center in Englewood, Colorado
University of Maryland Medical Center in Baltimore, Maryland
University of Texas Medical Branch in Galveston, Texas
出典: Wikipedia (英語), CC BY-SA 4.0 · Wikipediaで表示 ↗
DCTH 株価スナップショット 価格、時価総額、P/E、EPS、ROE、負債/資本、52週レンジ
株価
$17.21
時価総額
$597M
P/E (TTM)
245.9
EPS（TTM）
$0.07
収益（TTM）
$85M
配当利回り
—
ROE
2.5%
負債/自己資本
—
52週レンジ
$8 – $17
DCTH 株価チャート 技術指標付きの日次 OHLCV — パン、ズーム、ビューのカスタマイズ
Configure
10年間のパフォーマンス 収益、純利益、利益率、EPSのトレンド
収益と純利益
$85M
2016-12-31
→
2025-12-31
EPS
$0.07
2017-12-31
→
2025-12-31
フリーキャッシュフロー
$21M
2018-12-31
→
2025-12-31
利益率
3.2%
2022-12-31
→
2025-12-31
バリュエーション P/E、P/S、P/B、EV/EBITDA比率 — 株は割高か割安か？
指標
5年トレンド
DCTH
競合中央値
P/E (TTM)
245.9
32.9
P/S (TTM) (株価売上高倍率（TTM）)
7.0
4.6
P/B (株価純資産倍率)
5.4
3.5
Price / FCF (株価FCF倍率)
28.5
—
収益性 粗利益率、営業利益率、純利益率、ROE、ROA、ROIC
指標
5年トレンド
DCTH
競合中央値
Gross Margin (粗利益率)
86.2%
66.5%
Operating Margin (営業利益率)
0.77%
—
Net Profit Margin (純利益率)
3.2%
-9.8%
ROA
2.7%
-8.8%
ROE
2.5%
-15.5%
ROIC
0.46%
—
財務健全性 負債、流動性、支払能力 — バランスシートの健全性
指標
5年トレンド
DCTH
競合中央値
Current Ratio (流動比率)
10.9
4.8
Quick Ratio (クイックレシオ)
5.0
—
成長 収益、EPS、純利益の成長率：前年比、3年CAGR、5年CAGR
指標
5年トレンド
DCTH
競合中央値
Revenue YoY (収益（前年比）)
129.1%
—
Revenue CAGR 3Y (収益（3年CAGR）)
215.3%
—
資本効率 総資産回転率、棚卸資産回転率、売掛金回転率
指標
5年トレンド
DCTH
競合中央値
DCTH アナリストコンセンサス 強気・弱気のアナリストの見解、12ヶ月の目標株価、アップサイド
買い
12 アナリスト
- 強い買い 3 25.0%
- 買い 8 66.7%
- 保有 1 8.3%
- 売り 0 0.0%
- 強い売り 0 0.0%
12ヶ月目標株価
5 アナリスト · 2026-08-18
中央値
$22.00
平均値
$24.00
← 全目標を下回る
$17.21
安値
$21.00
高値
$32.00
中央値ターゲット
$22.00
+27.8%
平均値ターゲット
$24.00
+39.5%
決算履歴 EPS実績 vs 予想、サプライズ%、達成率、次回決算日
平均サプライズ
0.05%
| 期間 | EPS Actual | EPS 予想 | サプライズ |
|---|---|---|---|
| 2026年6月30日 | $0.07 | $-0.09 | 0.16% |
| 2026年3月31日 | $-0.03 | $-0.09 | 0.06% |
| 2025年12月31日 | $-0.05 | $-0.06 | 0.01% |
| 2025年9月30日 | $0.02 | $0.02 | -0.00% |
| 2025年6月30日 | $0.07 | $0.03 | 0.04% |
| 2025年3月31日 | $0.03 | $0.02 | 0.01% |
同業他社比較（GICSサブインダストリー） 主要メトリクスとセクターピアの比較
| ティッカー | 時価総額 | P/E | 売上高 YoY | 純利益率 | ROE | 粗利益率 |
|---|---|---|---|---|---|---|
| DCTH | $350M | 144.3 | 129.1% | 3.2% | 2.5% | 86.2% |
| BBNX | $1.35B | -16.8 | 53.9% | -73.0% | -24.9% | 55.4% |
| SSII | — | -94.7 | 105.7% | — | — | — |
| ANGO | $479M | -13.0 | 9.5% | -11.5% | -21.2% | 54.6% |
| TCMD | $651M | 35.4 | 12.5% | 5.8% | 9.2% | 75.9% |
| NPCE | $518M | -23.4 | 25.1% | -21.5% | -111.6% | 77.2% |
| VREX | $498M | -7.0 | 4.1% | -8.3% | -14.0% | 34.4% |
| CLPT | $402M | -15.2 | 17.8% | -69.1% | -106.9% | 61.4% |
| SGHT | $424M | -10.7 | -3.1% | -49.7% | -57.4% | 86.2% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
完全なファンダメンタルズ 年次別全指標 — 損益計算書、貸借対照表、キャッシュフロー
損益計算書 18
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $85M | $37M | $2M | $3M | $4M | · | · | · | $3M | $2M | $2M | $1M | |
| Cost of Revenue | $12M | $6M | $635.0K | $686.0K | $671.0K | $640.0K | $719.0K | $1M | $701.0K | $550.0K | $462.0K | $291.0K | |
| Gross Profit | $73M | $31M | $1M | $2M | $3M | $1M | $861.0K | $2M | $2M | $1M | $1M | $778.0K | |
| R&D Expense | $29M | $14M | $18M | $19M | $14M | $11M | $9M | $20M | $10M | $8M | $6M | $4M | |
| SG&A Expense | $44M | $30M | $22M | $17M | $14M | $11M | $11M | $10M | $10M | $9M | $10M | $16M | |
| Operating Expenses | $73M | $43M | $40M | $36M | $27M | $22M | $21M | $29M | $20M | $18M | $16M | $20M | |
| Operating Income | $660.0K | $-12M | $-38M | $-34M | $-25M | $-21M | $-20M | $-27M | $-18M | $-16M | $-15M | $-19M | |
| Interest Expense | · | · | · | · | · | · | · | · | $22M | $14M | $67.0K | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | $17.0K | $9.0K | $5.0K | |
| Other Non-op | $-70.0K | $-30.0K | $-59.0K | $30.0K | $68.0K | $154.0K | $2.0K | $51.0K | $-41.0K | $17.0K | $9.0K | $-24.0K | |
| Pretax Income | $4M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| Income Tax | $810.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $3M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| EPS (Basic) | $0.08 | $-0.93 | $-2.94 | $-4.12 | $-3.59 | $-8.35 | $-342.83 | $-0.72 | $-3250.00 | · | $-0.91 | $-1.84 | |
| EPS (Diluted) | $0.07 | $-0.93 | $-2.94 | $-4.12 | $-3.59 | $-8.35 | $-342.83 | $-0.72 | $-3250.00 | · | $-0.91 | $-1.84 | |
| Shares (Basic) | 35,821,157 | 28,511,393 | 16,229,931 | 8,864,615 | 7,145,754 | 2,897,827 | 25,900 | 26,705,375 | 14,039 | · | 16,161,687 | 9,452,050 | |
| Shares (Diluted) | 39,919,557 | 28,511,393 | 16,229,931 | 8,864,615 | 7,145,754 | 2,897,827 | 25,900 | 26,705,375 | 14,039 | · | 16,161,687 | 9,452,050 | |
| EBITDA | $660.0K | $-12M | $-38M | $-34M | $-25M | $-21M | $-20M | $-27M | · | · | $-15M | $-19M |
貸借対照表 25
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $32M | $13M | $8M | $23M | $29M | $10M | $3M | $4M | $4M | $13M | $20M | |
| Receivables | $12M | $11M | $241.0K | $366.0K | $44.0K | $57.0K | $21.0K | $585.0K | $317.0K | $403.0K | $277.0K | $174.0K | |
| Inventory | $10M | $7M | $3M | $2M | $1M | $855.0K | $654.0K | $858.0K | $1M | $660.0K | $757.0K | $349.0K | |
| Prepaid Expense | $6M | $3M | $1M | $2M | $3M | $3M | $2M | $898.0K | $700.0K | $698.0K | $960.0K | $974.0K | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $222.0K | |
| Current Assets | $120M | $74M | $37M | $16M | $31M | $32M | $13M | $6M | $8M | $34M | $15M | $22M | |
| PP&E (Net) | $3M | $2M | $1M | $1M | $1M | $1M | $735.0K | $925.0K | $1M | $1M | $1M | $2M | |
| PP&E (Gross) | $8M | $7M | $6M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $6M | |
| Accum. Depreciation | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | |
| Total Assets | $124M | $77M | $39M | $18M | $33M | $35M | $14M | $7M | $9M | $35M | $16M | $24M | |
| Accounts Payable | $3M | $961.0K | $1M | $2M | $638.0K | $2M | $5M | $8M | $4M | $594.0K | $284.0K | $748.0K | |
| Accrued Liabilities | $8M | $5M | $5M | $5M | $4M | $5M | $7M | $8M | $3M | $3M | $2M | $4M | |
| Current Liabilities | $11M | $6M | $16M | $15M | $6M | $10M | $16M | $18M | $8M | $36M | $6M | $5M | |
| Capital Leases | $835.0K | $933.0K | $0 | · | $207.0K | $450.0K | $197.0K | $0 | · | · | · | · | |
| Other Non-current Liabilities | $628.0K | $766.0K | $840.0K | $1M | $207.0K | · | $0 | $628.0K | $395.0K | $604.0K | $820.0K | $1M | |
| Total Liabilities | $12M | $8M | $23M | $24M | $21M | $13M | $21M | $22M | $8M | $37M | $7M | $6M | |
| Long-term Debt | · | $0 | $10M | $16M | · | · | · | · | · | · | · | · | |
| Common Stock | $347.0K | $331.0K | $228.0K | $100.0K | $79.0K | $60.0K | $1.0K | $0 | $2.0K | $0 | $14.0K | $97.0K | |
| Paid-in Capital | $639M | $600M | $521M | $452M | $433M | $417M | $365M | $329M | $326M | $278M | $270M | $265M | |
| Retained Earnings | $-529M | $-532M | $-505M | $-457M | $-421M | $-395M | $-371M | $-344M | $-325M | $-279M | $-261M | $-247M | |
| Treasury Stock | · | · | · | · | · | · | · | $0 | $51.0K | $51.0K | $51.0K | $51.0K | |
| AOCI | $575.0K | $82.0K | $135.0K | $-83.0K | $18.0K | $-104.0K | $28.0K | $50.0K | $42.0K | $-41.0K | $-8.0K | $20.0K | |
| Stockholders' Equity | $111M | $69M | $16M | $-6M | $12M | $22M | $-6M | $-15M | $678.0K | $-1M | $9M | $18M | |
| Liabilities + Equity | $124M | $77M | $39M | $18M | $33M | $35M | $14M | $7M | $9M | $35M | $16M | $24M | |
| Shares Outstanding | 34,691,671 | 33,061,002 | 22,761,554 | 10,046,571 | 7,906,728 | 5,996,101 | 67,091 | 14,715 | 228,139 | 11,750 | 1,360,239 | 9,708,841 |
キャッシュフロー 12
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Tax | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $23M | $-19M | $-31M | $-25M | $-23M | $-23M | $-24M | $-15M | $-15M | $-14M | $-16M | $-16M | |
| CapEx | $2M | $559.0K | $58.0K | $209.0K | $143.0K | $782.0K | $24.0K | $76.0K | $524.0K | $258.0K | $170.0K | $44.0K | |
| Investing Cash Flow | $-27M | $-981.0K | $-20M | $-209.0K | $-143.0K | $-782.0K | $-24.0K | $-76.0K | $-524.0K | · | · | · | |
| Net Debt Issued | · | $-11M | $-6M | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $481.0K | $250.0K | $123.0K | $0 | $2M | $230.0K | $0 | $11M | · | · | · | · | |
| Stock Repurchased | $6M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-6M | $250.0K | $123.0K | · | $2M | $230.0K | $0 | · | · | · | · | · | |
| Financing Cash Flow | $15M | $39M | $52M | $10M | $21M | $42M | $30M | $13M | $-11M | · | · | · | |
| Net Change in Cash | $11M | $20M | $874.0K | $-15M | $-2M | $19M | $7M | $-2M | $-26M | $-8M | $-8M | $-11M | |
| Taxes Paid | $2M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $21M | $-19M | $-31M | $-25M | $-23M | $-24M | $-24M | $-15M | · | · | $-17M | $-16M |
収益性 8
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 86.2% | 83.4% | 69.2% | 74.8% | · | · | · | · | · | · | 73.6% | 72.8% | |
| Operating Margin | 0.77% | -33.4% | -1849.0% | -1245.0% | · | · | · | · | · | · | -870.6% | -1805.8% | |
| Net Margin | 3.2% | -70.9% | -2308.9% | -1342.7% | · | · | · | · | · | · | -841.7% | -1625.9% | |
| Pretax Margin | 4.1% | -70.9% | -2308.9% | -1342.7% | · | · | · | · | · | · | -841.7% | · | |
| EBITDA Margin | 0.77% | -33.4% | -1849.0% | -1245.0% | · | · | · | · | · | · | -870.6% | -1805.8% | |
| ROA | 2.7% | -45.8% | -168.8% | -143.2% | -75.7% | -98.9% | -84.3% | -244.4% | · | · | -74.5% | -57.1% | |
| ROE | 2.5% | -68.2% | -235.5% | 657.5% | -216.7% | -190.6% | 70.5% | 194.1% | · | · | -109.9% | -72.0% | |
| ROIC | 0.46% | -18.1% | -242.0% | 577.8% | -205.3% | -96.5% | 313.2% | · | · | · | -176.8% | · |
流動性と支払能力 2
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.9 | 12.0 | 2.3 | 1.1 | 5.2 | 3.2 | 0.8 | 0.3 | · | · | 2.3 | 4.8 | |
| Quick Ratio | 5.0 | 7.0 | 0.8 | 0.5 | 3.8 | 2.9 | 0.6 | 0.2 | · | · | 2.0 | 4.5 |
効率性 3
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 0.6 | 0.1 | 0.1 | · | · | · | · | · | · | 0.1 | 0.0 | |
| Inventory Turnover | 1.4 | 1.2 | 0.2 | 0.4 | 0.6 | 0.8 | 1.0 | 1.0 | · | · | 0.8 | 0.5 | |
| Receivables Turnover | 7.5 | 6.7 | 6.8 | 13.3 | · | · | · | · | · | · | 7.7 | 4.1 |
成長率 2
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 129.1% | 1701.7% | -24.1% | -23.5% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 215.3% | 118.7% | · | · | · | · | · | · | · | · | · | · |
バリュエーション（TTM） 10
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $85M | $37M | $2M | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | |
| Net Income TTM | $3M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| Market Cap | $350M | $398M | $95M | $28M | $61M | $107M | $1M | $2.01B | · | · | · | · | |
| P/E | 144.3 | -12.9 | -1.4 | -0.9 | -2.2 | -2.1 | -0.1 | -272.2 | · | · | · | · | |
| P/S | 4.1 | 10.7 | 45.9 | 10.5 | 17.2 | 34.8 | 0.5 | 649.3 | · | · | · | · | |
| P/B | 3.2 | 5.8 | 6.0 | -4.9 | 5.1 | 4.9 | -0.2 | -134.2 | · | · | · | · | |
| P / Tangible Book | 3.2 | 5.8 | 6.0 | · | 5.1 | 4.9 | · | · | · | · | · | · | |
| P / Cash Flow | 15.6 | -21.3 | -3.0 | -1.1 | -2.7 | -4.7 | -0.1 | -136.1 | · | · | · | · | |
| P / FCF | 16.7 | -20.7 | -3.0 | -1.1 | -2.7 | -4.5 | -0.1 | -135.4 | · | · | · | · | |
| Earnings Yield | 0.69% | -7.7% | -70.7% | -114.4% | -46.3% | -46.6% | -1613.3% | -0.37% | · | · | · | · |
損益計算書 16
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29M | $25M | $21M | $21M | $24M | $20M | $15M | $11M | $8M | $3M | $539.0K | $434.0K | $495.0K | $597.0K | $638.0K | $906.0K | |
| Cost of Revenue | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $903.0K | $171.0K | $133.0K | $150.0K | $181.0K | $238.0K | $235.0K | |
| Gross Profit | $26M | $21M | $18M | $18M | $21M | $17M | $13M | $10M | $6M | $2M | $368.0K | $301.0K | $345.0K | $416.0K | $400.0K | $671.0K | |
| R&D Expense | $10M | $10M | $9M | $8M | $7M | $5M | $3M | $4M | $3M | $4M | $5M | $5M | $4M | $5M | $4M | $4M | |
| SG&A Expense | $13M | $13M | $11M | $10M | $11M | $11M | $7M | $7M | $7M | $9M | $7M | $6M | $5M | $4M | $4M | $5M | |
| Operating Expenses | $24M | $23M | $20M | $18M | $18M | $16M | $10M | $11M | $10M | $13M | $12M | $11M | $8M | $9M | $8M | $9M | |
| Operating Income | $2M | $-2M | $-2M | $-388.0K | $3M | $642.0K | $3M | $-1M | $-4M | $-10M | $-11M | $-11M | $-8M | $-8M | $-8M | $-8M | |
| Other Non-op | $-17.0K | $-58.0K | $-7.0K | $-33.0K | $-34.0K | $4.0K | $-53.0K | $35.0K | $10.0K | $-22.0K | $-73.0K | $-5.0K | $6.0K | $13.0K | $27.0K | $26.0K | |
| Pretax Income | $3M | $-908.0K | $-1M | $375.0K | $3M | $1M | $-3M | $2M | $-14M | $-11M | · | · | · | · | · | · | |
| Income Tax | $491.0K | $162.0K | $562.0K | $-455.0K | $508.0K | $195.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $3M | $-1M | $-2M | $830.0K | $3M | $1M | $-3M | $2M | $-14M | $-11M | $-11M | $-20M | $-7M | $-9M | $-8M | $-9M | |
| EPS (Basic) | $0.07 | $-0.03 | $-0.05 | $0.02 | $0.08 | $0.03 | $-0.06 | $0.06 | $-0.48 | $-0.45 | $-0.45 | $-1.14 | $-0.58 | $-0.77 | $-0.82 | $-0.96 | |
| EPS (Diluted) | $0.07 | $-0.03 | $-0.05 | $0.02 | $0.07 | $0.03 | $-0.06 | $0.06 | $-0.48 | $-0.45 | $-0.45 | $-1.14 | $-0.58 | $-0.77 | $-0.82 | $-0.96 | |
| Shares (Basic) | 35,891,915 | 36,021,210 | -70,991,574 | 36,383,277 | 35,786,813 | 34,642,641 | -53,478,825 | 28,738,307 | 28,364,731 | 24,887,180 | -25,719,196 | 17,863,078 | 12,463,665 | 11,622,384 | -16,732,137 | 9,215,786 | |
| Shares (Diluted) | 39,761,480 | 36,021,210 | -79,911,141 | 40,056,814 | 40,262,764 | 39,511,120 | -57,086,190 | 32,345,672 | 28,364,731 | 24,887,180 | -25,719,196 | 17,863,078 | 12,463,665 | 11,622,384 | -16,732,137 | 9,215,786 | |
| EBITDA | $2M | $-2M | · | $-388.0K | $3M | $642.0K | · | $-1M | $-4M | $-10M | · | $-11M | $-8M | $-8M | · | $-8M |
貸借対照表 23
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $48M | $41M | $43M | $42M | $34M | $13M | $32M | $8M | $15M | $12M | $13M | $40M | $15M | $24M | $8M | $10M | |
| Receivables | $16M | $14M | $12M | $14M | $16M | $14M | $11M | $7M | $4M | $2M | $241.0K | $205.0K | $127.0K | $458.0K | $366.0K | $537.0K | |
| Inventory | $12M | $10M | $10M | $11M | $11M | $7M | $7M | $7M | $6M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Prepaid Expense | $7M | $7M | $6M | $7M | $6M | $4M | $3M | $1M | $1M | $1M | $1M | $3M | $2M | $2M | $2M | $2M | |
| Current Assets | $131M | $120M | $120M | $121M | $113M | $84M | $74M | $29M | $31M | $34M | $37M | $46M | $19M | $29M | $16M | $18M | |
| PP&E (Net) | $4M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | $9M | $9M | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | |
| Accum. Depreciation | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Total Assets | $137M | $125M | $124M | $124M | $117M | $87M | $77M | $32M | $34M | $36M | $39M | $48M | $21M | $31M | $18M | $20M | |
| Accounts Payable | $4M | $3M | $3M | $2M | $5M | $2M | $961.0K | $937.0K | $3M | $1M | $1M | $753.0K | $966.0K | $2M | $2M | $3M | |
| Accrued Liabilities | $9M | $7M | $8M | $6M | $6M | $4M | $5M | $6M | $4M | $4M | $5M | $5M | $6M | $7M | $5M | $5M | |
| Current Liabilities | $13M | $11M | $11M | $8M | $10M | $5M | $6M | $22M | $12M | $13M | $16M | $14M | $11M | $13M | $15M | $14M | |
| Capital Leases | $2M | $815.0K | $835.0K | $855.0K | $877.0K | $906.0K | $933.0K | $963.0K | $989.0K | $1M | $0 | · | · | · | · | · | |
| Other Non-current Liabilities | $327.0K | $615.0K | $628.0K | $582.0K | $578.0K | $896.0K | $766.0K | $563.0K | $632.0K | $962.0K | $840.0K | $1M | $1M | $1M | $1M | $1M | |
| Total Liabilities | $16M | $12M | $12M | $9M | $12M | $7M | $8M | $23M | $30M | $21M | $23M | $23M | $21M | $25M | $24M | $25M | |
| Long-term Debt | · | · | · | · | · | · | · | $2M | $4M | $7M | $10M | · | · | · | $16M | · | |
| Common Stock | $346.0K | $344.0K | $347.0K | $353.0K | $350.0K | $334.0K | $331.0K | $280.0K | $279.0K | $254.0K | $228.0K | $197.0K | $153.0K | $101.0K | $100.0K | $86.0K | |
| Paid-in Capital | $648M | $642M | $639M | $641M | $632M | $610M | $600M | $536M | $534M | $530M | $521M | $519M | $473M | $453M | $452M | $442M | |
| Retained Earnings | $-527M | $-530M | $-529M | $-527M | $-528M | $-530M | $-532M | $-528M | $-530M | $-516M | $-505M | $-494M | $-474M | $-466M | $-457M | $-447M | |
| AOCI | $258.0K | $571.0K | $575.0K | $875.0K | $592.0K | $381.0K | $82.0K | $11.0K | $8.0K | $157.0K | $135.0K | $-59.0K | $-64.0K | $-64.0K | $-83.0K | $-57.0K | |
| Stockholders' Equity | $121M | $113M | $111M | $115M | $105M | $80M | $69M | $9M | $4M | $15M | $16M | $25M | $-242.0K | $-13M | $-6M | $-5M | |
| Liabilities + Equity | $137M | $125M | $124M | $124M | $117M | $87M | $77M | $32M | $34M | $36M | $39M | $48M | $21M | $31M | $18M | $20M | |
| Shares Outstanding | 34,636,252 | 34,465,087 | 34,691,671 | 35,308,939 | 34,955,974 | 33,436,612 | 33,061,002 | 28,019,599 | 27,931,393 | 25,439,319 | 22,761,554 | 19,688,991 | 15,250,469 | 10,046,571 | 10,046,571 | 8,597,682 |
キャッシュフロー 10
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6M | $857.0K | $8M | $5M | $7M | $2M | $-1M | $-4M | $-4M | $-10M | $-8M | $-9M | $-10M | $-4M | $-7M | $-5M | |
| CapEx | $503.0K | $570.0K | $550.0K | $459.0K | $398.0K | $140.0K | $229.0K | $216.0K | $101.0K | $13.0K | $19.0K | $-1.0K | $40.0K | $0 | $0 | $68.0K | |
| Investing Cash Flow | $-504.0K | $-571.0K | $-561.0K | $-466.0K | $-415.0K | $-25M | $-15M | $-697.0K | $10M | $5M | $-20M | $1.0K | $-40.0K | $0 | $0 | $-68.0K | |
| Stock Issued | $0 | $389.0K | $0 | $243.0K | $0 | $238.0K | $0 | $175.0K | $0 | $75.0K | $0 | $76.0K | $0 | $47.0K | $0 | $0 | |
| Stock Repurchased | $11.0K | $3M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-3M | · | · | · | $238.0K | · | · | · | $75.0K | · | · | · | $47.0K | · | · | |
| Financing Cash Flow | $962.0K | $-2M | $-6M | $3M | $15M | $3M | $40M | $-2M | $-3M | $4M | $1.0K | $35M | $7.0K | $17M | $5M | $5M | |
| Net Change in Cash | $6M | $-2M | $2M | $7M | $22M | $-20M | $24M | $-6M | $3M | $-886.0K | $-28M | $26M | $-10M | $12M | $-2M | $-372.0K | |
| Taxes Paid | · | · | $228.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $287.0K | · | · | · | $2M | · | · | · | $-10M | · | · | · | $-4M | · | · |
収益性 8
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 89.8% | 85.0% | · | 87.2% | 86.3% | 85.6% | · | 85.4% | 80.4% | 71.2% | · | 69.3% | 69.7% | 69.7% | · | · | |
| Operating Margin | 8.2% | -6.6% | · | -1.9% | 10.7% | 3.2% | · | -11.2% | -50.4% | -327.4% | · | -2432.3% | -1615.6% | -1394.5% | · | · | |
| Net Margin | 9.2% | -4.3% | · | 4.0% | 11.2% | 5.4% | · | 16.6% | -176.9% | -354.0% | · | -4686.6% | -1455.0% | -1507.5% | · | · | |
| Pretax Margin | 10.8% | -3.6% | · | 1.8% | 13.3% | 6.4% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | 8.2% | -6.6% | · | -1.9% | 10.7% | 3.2% | · | -11.2% | -50.4% | -327.4% | · | -2432.3% | -1615.6% | -1394.5% | · | · | |
| ROA | 2.1% | -1.0% | · | 1.1% | 3.6% | 1.7% | · | 4.7% | -50.0% | -33.3% | · | -60.0% | -34.2% | -31.1% | · | -31.1% | |
| ROE | 2.4% | -1.1% | · | 1.4% | 4.9% | 2.2% | · | 11.2% | -695.8% | -1439.2% | · | -208.9% | 466.5% | 229.3% | · | -262.5% | |
| ROIC | 1.7% | -1.7% | · | -0.75% | 2.1% | 0.68% | · | · | · | · | · | · | · | · | · | · |
流動性と支払能力 2
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.8 | 11.2 | · | 15.1 | 10.9 | 16.0 | · | 1.3 | 2.6 | 2.5 | · | 3.3 | 1.8 | 2.2 | · | 1.3 | |
| Quick Ratio | 4.8 | 5.2 | · | 6.9 | 4.8 | 5.1 | · | 0.7 | 1.5 | 1.0 | · | 2.9 | 1.3 | 1.8 | · | 0.7 |
効率性 3
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Inventory Turnover | 0.3 | 0.4 | · | 0.3 | 0.4 | 0.5 | · | 0.4 | 0.3 | 0.3 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.8 | 1.8 | · | 2.0 | 2.5 | 2.6 | · | 3.1 | 4.0 | 3.1 | · | 1.2 | 1.8 | 1.9 | · | · |
バリュエーション（TTM） 10
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $99M | $89M | · | $76M | $63M | $42M | · | $23M | $12M | $5M | · | $2M | $3M | $3M | · | · | |
| Net Income TTM | $5M | $4M | · | $6M | $-8M | $-22M | · | $-43M | $-52M | $-48M | · | $-45M | $-35M | $-37M | · | $-35M | |
| Market Cap | $436M | $320M | · | $380M | $475M | $426M | · | $253M | $234M | $121M | · | $80M | $89M | $58M | · | $28M | |
| P/E | 96.8 | 103.1 | · | 59.7 | -42.5 | -15.2 | · | -4.5 | -3.2 | -1.6 | · | -1.2 | -1.6 | -1.4 | · | -0.8 | |
| P/S | 4.4 | 3.6 | · | 5.0 | 7.6 | 10.2 | · | 11.2 | 19.8 | 26.0 | · | 32.8 | 31.8 | 21.6 | · | · | |
| P/B | 3.6 | 2.8 | · | 3.3 | 4.5 | 5.3 | · | 29.5 | 55.8 | 8.3 | · | 3.2 | -367.4 | -4.4 | · | -5.2 | |
| P / Tangible Book | 3.6 | 2.8 | · | 3.3 | 4.5 | 5.3 | · | 29.5 | 55.8 | 8.3 | · | 3.2 | · | · | · | · | |
| P / Cash Flow | · | 373.2 | · | · | · | 193.2 | · | · | · | -12.7 | · | · | · | -13.5 | · | · | |
| P / FCF | · | 1114.4 | · | · | · | 206.3 | · | · | · | -12.6 | · | · | · | -13.5 | · | · | |
| Earnings Yield | 1.0% | 0.97% | · | 1.7% | -2.4% | -6.6% | · | -22.3% | -31.7% | -61.6% | · | -85.2% | -60.9% | -70.8% | · | -132.5% |
財務諸表 損益計算書、貸借対照表、キャッシュフロー — 年次、過去5年間
損益計算書
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 収益 | $85M | $37M | $2M | $3M | $4M |
| 粗利益率 % | 86.2% | 83.4% | 69.2% | 74.8% | — |
| 営業利益率 % | 0.77% | -33.4% | -1849.0% | -1245.0% | — |
| 純利益 | $3M | $-26M | $-48M | $-37M | $-26M |
| 希薄化後EPS | $0.07 | $-0.93 | $-2.94 | $-4.12 | $-3.59 |
貸借対照表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流動比率 | 10.9 | 12.0 | 2.3 | 1.1 | 5.2 |
| クイックレシオ | 5.0 | 7.0 | 0.8 | 0.5 | 3.8 |
キャッシュフロー
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| フリーキャッシュフロー | $21M | $-19M | $-31M | $-25M | $-23M |
マイ指標 あなた専用のウォッチリスト — 決算詳細から選択した行
📊
あなたにとって重要なメトリクスを選択 — 上記の決算詳細の任意の行の横にある➕をクリックしてください。
選択内容は保存され、すべてのティッカーで引き継がれます。
機関投資家（13F） 140 提出者 · $188.2M合計 · 時点 2026年6月30日
四半期SECフォーム13Fでこの株式の保有を報告している機関。ロングポジションのみ。単一の提出者は、別々のオプションレッグで2回表示される場合があります。 大きな反対売買のプット/コール・レッグは、通常、マーケットメイクまたはヘッジされた在庫を反映しており、方向性への確信を示すものではありません。
機関投資家の動向 — Q2 2026 対 前四半期
| 新規ポジション | 解消済みポジション | 増加 | 減少 | 純株式数増減 |
|---|---|---|---|---|
| 27 (0 前期比) | 17 (-3 前期比) | 40 (+6 前期比) | 30 (-7 前期比) | +1.7M |
Q1 2026と比較しました。 SECフォーム13Fの提出期限は四半期末から45日後ですが、遅延提出者向けの短いバッファーが含まれます。この期間内の四半期は、直近で完全に報告されたペアを優先するためスキップされます。
| 機関投資家 | 評価額 | 株式数 | % 追跡された13Fのうち | タイプ |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | $41,551,898 | 3,300,389 | 22.08% | 株式数 |
| VANGUARD CAPITAL MANAGEMENT LLC | $15,375,500 | 1,221,247 | 8.17% | 株式数 |
| VANGUARD GROUP INC | $14,879,573 | 1,473,225 | 7.91% | 株式数 |
| Propel Bio Management, LLC | $10,971,681 | 871,460 | 5.83% | 株式数 |
| STATE STREET CORP | $8,552,135 | 679,280 | 4.55% | 株式数 |
| GEODE CAPITAL MANAGEMENT, LLC | $7,923,535 | 629,139 | 4.21% | 株式数 |
| ALGERT GLOBAL LLC | $7,311,114 | 580,708 | 3.89% | 株式数 |
| MILLENNIUM MANAGEMENT LLC | $7,130,611 | 566,371 | 3.79% | 株式数 |
| Divisadero Street Capital Management, LP | $6,292,432 | 499,796 | 3.34% | 株式数 |
| ExodusPoint Capital Management, LP | $4,530,940 | 359,884 | 2.41% | 株式数 |
| Private Wealth Advisors, LLC | $3,913,765 | 310,863 | 2.08% | 株式数 |
| Simplify Asset Management Inc. | $3,333,454 | 264,770 | 1.77% | 株式数 |
| BlackRock, Inc. | $3,180,738 | 252,640 | 1.69% | 株式数 |
| ADAR1 Capital Management, LLC | $2,825,007 | 224,385 | 1.50% | 株式数 |
| DIMENSIONAL FUND ADVISORS LP | $2,570,450 | 204,166 | 1.37% | 株式数 |
| KENNEDY CAPITAL MANAGEMENT LLC | $2,570,160 | 204,143 | 1.37% | 株式数 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2,435,510 | 193,448 | 1.29% | 株式数 |
| Ikarian Capital, LLC | $2,337,548 | 185,667 | 1.24% | 株式数 |
| VANGUARD FIDUCIARY TRUST CO | $2,290,159 | 181,903 | 1.22% | 株式数 |
| CIBC WORLD MARKET INC. | $2,054,789 | 163,208 | 1.09% | 株式数 |
| Caption Management, LLC | $1,894,795 | 150,500 | 1.01% | プットオプション |
| GOLDMAN SACHS GROUP INC | $1,885,353 | 149,750 | 1.00% | 株式数 |
| Lane Generational LLC | $1,884,257 | 149,663 | 1.00% | 株式数 |
| HSBC HOLDINGS PLC | $1,705,848 | 135,600 | 0.91% | 株式数 |
| Man Group plc | $1,617,752 | 128,495 | 0.86% | 株式数 |
| Cubist Systematic Strategies, LLC | $1,562,514 | 145,350 | 0.83% | 株式数 |
| Diametric Capital, LP | $1,546,568 | 122,841 | 0.82% | 株式数 |
| MORGAN STANLEY | $1,366,506 | 108,539 | 0.73% | 株式数 |
| BARCLAYS PLC | $1,354,243 | 107,565 | 0.72% | 株式数 |
| Caption Management, LLC | $1,259,000 | 100,000 | 0.67% | コールオプション |
| Capital Advisors Wealth Management, LLC | $1,170,870 | 93,000 | 0.62% | 株式数 |
| Jefferies Financial Group Inc. | $1,057,308 | 83,980 | 0.56% | 株式数 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1,050,824 | 83,465 | 0.56% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,022,308 | 81,200 | 0.54% | コールオプション |
| Stonepine Capital Management, LLC | $1,000,000 | 100,000 | 0.53% | コールオプション |
| Caption Management, LLC | $978,243 | 77,700 | 0.52% | 株式数 |
| FOX RUN MANAGEMENT, L.L.C. | $776,526 | 61,678 | 0.41% | 株式数 |
| Quantbot Technologies LP | $749,860 | 59,560 | 0.40% | 株式数 |
| D. E. Shaw & Co., Inc. | $728,885 | 57,894 | 0.39% | 株式数 |
| BNP PARIBAS FINANCIAL MARKETS | $725,864 | 57,654 | 0.39% | 株式数 |
| Pale Fire Capital SE | $504,670 | 40,085 | 0.27% | 株式数 |
| BANK OF AMERICA CORP /DE/ | $493,931 | 39,232 | 0.26% | 株式数 |
| WOLVERINE TRADING, LLC | $479,600 | 44,000 | 0.25% | コールオプション |
| RHUMBLINE ADVISERS | $458,822 | 36,444 | 0.24% | 株式数 |
| ALPS ADVISORS INC | $441,154 | 35,040 | 0.23% | 株式数 |
| EntryPoint Capital, LLC | $437,641 | 34,761 | 0.23% | 株式数 |
| SEI INVESTMENTS CO | $394,936 | 31,369 | 0.21% | 株式数 |
| AMERICAN CENTURY COMPANIES INC | $378,380 | 30,054 | 0.20% | 株式数 |
| Balyasny Asset Management L.P. | $358,412 | 28,468 | 0.19% | 株式数 |
| Leonteq Securities AG | $348,730 | 27,699 | 0.19% | 株式数 |
| CITADEL ADVISORS LLC | $334,894 | 26,600 | 0.18% | コールオプション |
| BOOTHBAY FUND MANAGEMENT, LLC | $319,484 | 25,376 | 0.17% | 株式数 |
| Xcelsior Advisor Partners LLC | $318,527 | 25,300 | 0.17% | 株式数 |
| Palisades Investment Partners, LLC | $293,007 | 23,273 | 0.16% | 株式数 |
| WOLVERINE TRADING, LLC | $269,666 | 24,740 | 0.14% | 株式数 |
| ALLIANCEBERNSTEIN L.P. | $239,424 | 25,800 | 0.13% | 株式数 |
| MetLife Investment Management, LLC | $235,043 | 18,669 | 0.12% | 株式数 |
| Bank of New York Mellon Corp | $234,942 | 18,661 | 0.12% | 株式数 |
| WealthPlan Investment Management, LLC | $219,607 | 17,443 | 0.12% | 株式数 |
| NOMURA HOLDINGS INC | $210,530 | 16,722 | 0.11% | 株式数 |
| WOLVERINE TRADING, LLC | $209,280 | 19,200 | 0.11% | プットオプション |
| CITADEL ADVISORS LLC | $202,699 | 16,100 | 0.11% | プットオプション |
| CITADEL ADVISORS LLC | $189,391 | 15,043 | 0.10% | 株式数 |
| SkyOak Wealth, LLC | $188,850 | 15,000 | 0.10% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $188,850 | 15,000 | 0.10% | プットオプション |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $166,729 | 13,243 | 0.09% | 株式数 |
| TUDOR INVESTMENT CORP ET AL | $151,609 | 12,042 | 0.08% | 株式数 |
| LANARK FINANCIAL, INC. | $150,500 | 11,954 | 0.08% | 株式数 |
| CITIGROUP INC | $146,485 | 11,635 | 0.08% | 株式数 |
| Invesco Ltd. | $143,790 | 11,421 | 0.08% | 株式数 |
| MERCER GLOBAL ADVISORS INC /ADV | $140,744 | 11,179 | 0.07% | 株式数 |
| Nuveen, LLC | $138,754 | 11,021 | 0.07% | 株式数 |
| Vanguard Global Advisers, LLC | $133,869 | 10,633 | 0.07% | 株式数 |
| Schonfeld Strategic Advisors LLC | $131,136 | 10,416 | 0.07% | 株式数 |
| LPL Financial LLC | $128,859 | 10,235 | 0.07% | 株式数 |
| TWO SIGMA INVESTMENTS, LP | $126,580 | 10,054 | 0.07% | 株式数 |
| Police & Firemen's Retirement System of New Jersey | $110,729 | 8,795 | 0.06% | 株式数 |
| SHERBROOKE PARK ADVISERS LLC | $109,918 | 10,883 | 0.06% | 株式数 |
| Hunting Hill Global Capital, LLC | $104,716 | 11,284 | 0.06% | 株式数 |
| MARSHALL WACE, LLP | $84,177 | 6,686 | 0.04% | 株式数 |
| FMR LLC | $69,144 | 5,492 | 0.04% | 株式数 |
| Private Wealth Advisors, LLC | $62,950 | 5,000 | 0.03% | コールオプション |
| NEW YORK STATE COMMON RETIREMENT FUND | $60,432 | 4,800 | 0.03% | 株式数 |
| OSAIC HOLDINGS, INC. | $60,254 | 4,786 | 0.03% | 株式数 |
| Point72 (DIFC) Ltd | $53,931 | 5,017 | 0.03% | 株式数 |
| NORTHERN TRUST CORP | $53,797 | 4,273 | 0.03% | 株式数 |
| Persistent Asset Partners Ltd | $52,954 | 4,206 | 0.03% | 株式数 |
| Arax Advisory Partners | $51,884 | 4,121 | 0.03% | 株式数 |
| IFP Advisors, Inc | $51,657 | 4,103 | 0.03% | 株式数 |
| Integrated Wealth Concepts LLC | $48,145 | 3,824 | 0.03% | 株式数 |
| Ameritas Investment Partners, Inc. | $38,714 | 3,075 | 0.02% | 株式数 |
| Legal & General Group Plc | $34,534 | 2,743 | 0.02% | 株式数 |
| CWM, LLC | $29,343 | 3,162 | 0.02% | 株式数 |
| Creative Planning | $17,777 | 1,412 | 0.01% | 株式数 |
| Tripletail Wealth Management, LLC | $16,632 | 1,260 | 0.01% | 株式数 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $14,950 | 1,611 | 0.01% | 株式数 |
| AlphaQuest LLC | $14,473 | 1,433 | 0.01% | 株式数 |
| Tower Research Capital LLC (TRC) | $13,711 | 1,089 | 0.01% | 株式数 |
| Activest Wealth Management | $12,590 | 1,000 | 0.01% | 株式数 |
| Geneos Wealth Management Inc. | $11,621 | 923 | 0.01% | 株式数 |
企業インサイダー 46 人のインサイダー · 11人の役員 · 16人の取締役
| インサイダー | 役職 | 最終アクティビティ | 保有株式数 | 12ヶ月購入 | 12ヶ月売却 | 12ヶ月純額 |
|---|---|---|---|---|---|---|
| Jennifer K. Simpson | President and CEO | 2020年5月8日 C | 25,021 | 0 | 0 | $0 |
| Barbra Keck | Chief Financial Officer, Secretary | 2020年5月8日 C | 12,851 | 0 | 0 | $0 |
| Paul M Feinstein | Chief Financial Officer | 2007年11月30日 A | 3,375 | 0 | 0 | $0 |
| John Purpura | Chief Operating Officer | 2023年10月13日 P | 41,526 | 0 | 0 | $0 |
| HERSCHKOWITZ SAMUEL /FA/ | Chief Operating Officer | 2007年5月29日 P | 160,375 | 0 | 0 | $0 |
| Vojo Vukovic | Chief Medical Officer | 2023年12月12日 P | 100,000 | 0 | 0 | $0 |
| Sandra Pennell | SVP of Finance, PFO and PAO | 2023年11月17日 P | 30,000 | 0 | 0 | $0 |
| David L. Hoffman | General Counsel, Chief Compliance Officer and Secretary | 2023年11月16日 P | 40,000 | 0 | 0 | $0 |
| Kevin Muir | Vice President Commercial Operations | 2023年6月12日 A | — | 0 | 0 | $0 |
| Johnny John | Senior Vice President Clinical Development and Medical Affairs | 2023年6月12日 A | — | 0 | 0 | $0 |
| Christine Padula | Interim Principal Accounting Officer | 2021年9月1日 A | — | 0 | 0 | $0 |
| John Richard Sylvester | 取締役 | 2023年8月21日 P | 10,550 | 0 | 0 | $0 |
| Aharon Gil | 取締役 | 2023年6月12日 A | 404,000 | 0 | 0 | $0 |
| Steven A J Salamon | 取締役 | 2023年6月12日 A | 440,100 | 0 | 0 | $0 |
| Roger G Stoll PHD | 取締役 | 2023年6月12日 A | 9,309 | 0 | 0 | $0 |
| Rosalind Advisors, Inc. | 取締役 | 2022年4月19日 P | 433,100 | 0 | 0 | $0 |
| Marco Taglietti | 取締役 | 2020年5月8日 C | 6,000 | 0 | 0 | $0 |
| William Dodge Rueckert | 取締役 | 2020年5月8日 C | 6,014 | 0 | 0 | $0 |
| Simon Pedder | 取締役 | 2019年2月1日 A | — | 0 | 0 | $0 |
| Laura A Philips | 取締役 | 2015年7月23日 P | 205,299 | 0 | 0 | $0 |
| Harold S Koplewicz | 取締役 | 2015年6月10日 A | 45,052 | 0 | 0 | $0 |
| Dennis Langer | 取締役 | 2015年6月10日 A | 20,000 | 0 | 0 | $0 |
| Jonathan Lewis | 取締役 | 2008年6月30日 A | 10,000 | 0 | 0 | $0 |
| Mark Corigliano | 取締役 | 2007年4月16日 M | 198,176 | 0 | 0 | $0 |
| Daniel Isdaner | 取締役 | 2007年4月16日 M | 253,668 | 0 | 0 | $0 |
| Elizabeth Czerepak | — | 2026年5月13日 A | — | 0 | 0 | $0 |
| Gerard J Michel | — | 2026年3月2日 P | 342,034 | 2 | 0 | $198,447 |
| Laura Brege | — | 2014年7月7日 A | 11,678 | 0 | 0 | $0 |
| Tasos Konidaris | — | 2014年7月7日 A | 11,678 | 0 | 0 | $0 |
| Gabriel Leung | — | 2014年7月7日 A | 21,485 | 0 | 0 | $0 |
| Douglas G Watson | — | 2014年7月7日 A | 136,664 | 0 | 0 | $0 |
| Graham G Miao | — | 2013年11月14日 A | 54,000 | 0 | 0 | $0 |
| Peter J Graham | — | 2013年11月14日 A | 15,000 | 0 | 0 | $0 |
| William M Appling | — | 2013年7月15日 A | — | 0 | 0 | $0 |
| Krishna Kandarpa | — | 2013年3月11日 A | 159,000 | 0 | 0 | $0 |
| Harold Mapes | — | 2013年3月11日 A | 17,000 | 0 | 0 | $0 |
| Eamonn P Hobbs | — | 2013年3月11日 A | 162,000 | 0 | 0 | $0 |
| Agustin V Gago | — | 2013年3月11日 A | 80,944 | 0 | 0 | $0 |
| Robert Ladd | — | 2012年6月15日 A | 69,534 | 0 | 0 | $0 |
| David Mcdonald | — | 2011年3月10日 A | 47,706 | 0 | 0 | $0 |
| Pamela Reilly Contag | — | 2010年12月1日 A | 8,507 | 0 | 0 | $0 |
| Richard Taney | — | 2009年12月10日 A | 211,485 | 0 | 0 | $0 |
| Jason Andrew Rifkin | — | 2009年10月12日 A | — | 0 | 0 | $0 |
| KOLY M S /FA/ | — | 2007年1月26日 X | 775,360 | 0 | 0 | $0 |
| Victor Nevins | — | 2006年10月12日 M | 180,007 | 0 | 0 | $0 |
| VENKOL TRUST | — | 2004年11月10日 J | 892,649 | 0 | 0 | $0 |
SECフォーム3/4/5提出書類からのインサイダー；純額＝公開市場のP/Sのみ
アクティビストおよび5%超のオーナー 17保有
SECスケジュール13Dを提出した投資家 — 発行体の影響を与える意図（アクティビストの保有、取締役会キャンペーン、M&A）を持つ5%超の受益権所有。各行は、その提出者のポジションの最新の既知の状態を示します。
| 提出者 | 提出済み | 保有 | ステータス | 目的 | 提出書類 |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc., SALAMON STEVEN A J, Aharon Gil, Rosalind Master Fund L.P., Rosalind Opportunities Fund I L.P. ×15 提出書類 | 2026年2月10日 | 9.90% | 修正 | — | SEC |
| 未開示の報告者 | 2022年12月16日 | — | 初回提出 | 受動的投資 | SEC |
| 未開示の報告者 | 2022年7月27日 | — | 初回提出 | 受動的投資 | SEC |
| Laddcap Value Partners LP S.S. or, Laddcap Value Associates LLC S.S. or, Laddcap Value Advisors LLC S.S. or, Robert Ladd S.S. or ×2 提出書類 | 2010年8月2日 | — | 初回提出 | — | SEC |
| Robert Ladd | 2006年10月18日 | — | 初回提出 | 受動的投資 | SEC |
| 未開示の報告者 | 2006年7月28日 | — | 初回提出 | 取締役会キャンペーン | SEC |
| 未開示の報告者 | 2006年7月11日 | — | 初回提出 | — | SEC |
| 未開示の報告者 | 2006年6月14日 | — | 初回提出 | — | SEC |
| 未開示の報告者 | 2006年6月8日 | — | 初回提出 | — | SEC |
| 未開示の報告者 | 2006年5月24日 | — | 初回提出 | — | SEC |
| 未開示の報告者 | 2006年4月28日 | — | 初回提出 | — | SEC |
| 未開示の報告者 | 2006年1月10日 | — | 初回提出 | — | SEC |
| 未開示の報告者 | 2006年1月6日 | — | 初回提出 | — | SEC |
| 未開示の報告者 | 2005年12月14日 | — | 初回提出 | — | SEC |
| 未開示の報告者 | 2005年11月10日 | — | 初回提出 | 取締役会キャンペーン | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF保有状況 22のETFが保有
ウェイトは直接株式保有（N-PORT）のみを反映しています。レバレッジ型またはデリバティブベースのファンドは、表示されていない追加のスワップエクスポージャーを保有している可能性があります。
| ファンド | ウェイト | 単位 | 時点 | ソース |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0.24% | 35,814 NS | 2026年5月31日 | N-PORT |
| IWC · iShares Trust | 0.10% | 97,850 SH | 2026年8月8日 | 日次 |
| GSSC · Goldman Sachs ETF Trust | 0.04% | 35,321 NS | 2026年5月31日 | N-PORT |
| IWN · iShares Trust | 0.02% | 227,534 SH | 2026年8月8日 | 日次 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 21,358 SH | 2026年8月8日 | 日次 |
| IWM · iShares Trust | 0.01% | 741,852 SH | 2026年8月8日 | 日次 |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.01% | 2,388 SH | 2026年8月8日 | 日次 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 165,177 SH | 2026年8月8日 | 日次 |
| RSSL · Global X Funds | 0.01% | 13,080 NS | 2026年4月30日 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.01% | 22,609 NS | 2026年5月31日 | N-PORT |
| ITWO · ProShares Trust | 0.01% | 1,420 NS | 2026年5月31日 | N-PORT |
| UWM · ProShares Trust | 0.00% | 1,111 NS | 2026年5月31日 | N-PORT |
| IWO · iShares Trust | 0.00% | 38,572 SH | 2026年8月8日 | 日次 |
| URTY · ProShares Trust | 0.00% | 1,122 NS | 2026年5月31日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,638 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.00% | 28 NS | 2026年5月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.00% | 19,222 NS | 2026年4月30日 | N-PORT |
| ITOT · iShares Trust | 0.00% | 43,750 SH | 2026年8月8日 | 日次 |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 304,809 SH | 2026年8月8日 | 日次 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 889,410 SH | 2026年8月8日 | 日次 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 4,438 SH | 2026年8月8日 | 日次 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2,475 SH | 2026年8月8日 | 日次 |